Sanders MF, Blankestijn PJ, Voskuil M, Spiering W, Vonken EJ, Rotmans JI, van der Hoeven BL, Daemen J, van den Meiracker AH, Kroon AA, de Haan MW, Das M, Bax M, van der Meer IM, van Overhagen H, van den Born BJH, van Brussel PM, van der Valk PHM, Smak Gregoor PJH, Meuwissen M, Gomes MER, Oude Ophuis T, Troe E, Tonino WAL, Konings CJAM, de Vries PAM, van Balen A, Heeg JE, Smit JJJ, Elvan A, Steggerda R, Niamut SML, Peels JOJ, de Swart JBRM, Wardeh AJ, Groeneveld JHM, van der Linden E, Hemmelder MH, Folkeringa R, Stoel MG, Kant GD, Herrman JPR, van Wissen S, Deinum J, Westra SW, Aengevaeren WRM, Parlevliet KJ, Schramm A, Jessurun GAJ, Rensing BJWM, Winkens MHM, Wierema TKA, Santegoets E, Lipsic E, Houwerzijl E, Kater M, Allaart CP, Nap A, Bots ML. Safety and long-term effects of renal denervation: Rationale and design of the Dutch registry.
Neth J Med 2016;
74:5-15. [PMID:
26819356]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
BACKGROUND
Percutaneous renal denervation (RDN) has recently been introduced as a treatment for therapy-resistant hypertension. Also, it has been suggested that RDN may be beneficial for other conditions characterised by increased sympathetic nerve activity. There are still many uncertainties with regard to efficacy, safety, predictors for success and long-term effects. To answer these important questions, we initiated a Dutch RDN registry aiming to collect data from all RDN procedures performed in the Netherlands.
METHODS
The Dutch RDN registry is an ongoing investigator-initiated, prospective, multicentre cohort study. Twenty-six Dutch hospitals agreed to participate in this registry. All patients who undergo RDN, regardless of the clinical indication or device that is used, will be included. Data are currently being collected on eligibility and screening, treatment and follow-up.
RESULTS
Procedures have been performed since August 2010. At present, data from 306 patients have been entered into the database. The main indication for RDN was hypertension (n = 302, 99%). Patients had a mean office blood pressure of 177/100 (±29/16) mmHg with a median use of three (range 0-8) blood pressure lowering drugs. Mean 24-hour blood pressure before RDN was 157/93 (±18/13) mmHg. RDN was performed with different devices, with the Simplicity™ catheter currently used most frequently.
CONCLUSION
Here we report on the rationale and design of the Dutch RDN registry. Enrolment in this investigator-initiated study is ongoing. We present baseline characteristics of the first 306 participants.
Collapse